ScreenerHero

VYNE VYNE Therapeutics Inc.

Partial data
NAS · US · Healthcare · Biotechnology · vynetherapeutics.com
28.56USD+12.22%Mkt Cap: 19.07M $P/E: —

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a t…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated - Common Stock
$126.58BUSDP/E 29.1
MRNA
Moderna, Inc. - Common Stock
$87.04BUSD
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
$81.41BUSDP/E 19.6
CSL
CSL Limited
$64.18BUSD
ARGX
argenx SE - American Depositary Shares
$51.51BUSDP/E 31.2
ARGX
ARGENX SE
$51.49BUSDP/E 32.4
UCB
UCB S.A.
$43.90BUSDP/E 18.1
ONC
BeOne Medicines Ltd. - American Depositary Shares
$41.99BUSDP/E 66.0
RVMD
Revolution Medicines, Inc. - Common Stock
$38.14BUSD
RPRX
Royalty Pharma plc - Class A Ordinary Shares
$35.22BUSDP/E 32.4
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
$31.02BUSDP/E 39.1
ROIV
Roivant Sciences Ltd. - Common Shares
$24.22BUSD
GMAB
Genmab A/S
$23.16BUSDP/E 31.4
INCY
Incyte Corporation - Common Stock
$22.92BUSDP/E 14.4
GMAB
Genmab A/S - American Depositary Shares
$22.75BUSDP/E 29.1
BNTX
BioNTech SE - American Depositary Shares
$22.03BUSD
INSM
Insmed Incorporated - Common Stock
$21.02BUSD
EXEL
Exelixis, Inc. - Common Stock
$15.42BUSDP/E 19.6
ASND
Ascendis Pharma A/S - Ordinary Share
$14.82BUSDP/E 17.3
HALO
Halozyme Therapeutics, Inc. - Common Stock
$13.83BUSDP/E 35.6